Brookline Capital Management Forecasts BIOX Q4 Earnings

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) – Equities research analysts at Brookline Capital Management cut their Q4 2025 earnings estimates for shares of Bioceres Crop Solutions in a note issued to investors on Tuesday, November 12th. Brookline Capital Management analyst K. Dolliver now expects that the company will post earnings of $0.09 per share for the quarter, down from their previous forecast of $0.13. The consensus estimate for Bioceres Crop Solutions’ current full-year earnings is $0.33 per share.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same period in the previous year, the business posted ($0.07) earnings per share.

A number of other equities research analysts also recently commented on the company. Canaccord Genuity Group dropped their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a report on Wednesday. Oppenheimer lowered their price target on Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research note on Monday, October 21st. Roth Mkm reduced their price objective on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Canaccord Genuity Group raised shares of Bioceres Crop Solutions to a “strong-buy” rating in a research note on Friday, July 19th. Finally, Lake Street Capital reduced their price target on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Four investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, Bioceres Crop Solutions presently has an average rating of “Buy” and a consensus target price of $12.13.

Bioceres Crop Solutions Stock Performance

BIOX stock opened at $6.17 on Thursday. Bioceres Crop Solutions has a twelve month low of $5.71 and a twelve month high of $14.05. The company has a quick ratio of 0.86, a current ratio of 1.27 and a debt-to-equity ratio of 0.37. The company has a market cap of $387.78 million, a P/E ratio of 321.16 and a beta of 0.49. The business’s fifty day moving average is $7.58 and its 200-day moving average is $9.80.

Institutional Trading of Bioceres Crop Solutions

Large investors have recently bought and sold shares of the business. Oak Family Advisors LLC boosted its holdings in shares of Bioceres Crop Solutions by 1.9% in the second quarter. Oak Family Advisors LLC now owns 64,925 shares of the company’s stock valued at $728,000 after buying an additional 1,208 shares during the period. Dimensional Fund Advisors LP lifted its position in Bioceres Crop Solutions by 9.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after acquiring an additional 5,341 shares in the last quarter. Stifel Financial Corp boosted its stake in Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the period. Oppenheimer & Co. Inc. bought a new position in Bioceres Crop Solutions during the 1st quarter worth about $139,000. Finally, Lazard Asset Management LLC acquired a new stake in shares of Bioceres Crop Solutions in the 1st quarter valued at about $212,000. 17.68% of the stock is owned by institutional investors.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.